Deciphera Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Deciphera Pharmaceuticals

08/02/2022 22:37

* Deciphera Pharmaceuticals Inc  DCPH.OQ  reported a
quarterly
adjusted loss of $1.51​​ per share for the quarter ended in
December. The mean expectation of eleven analysts for the
quarter was for a loss of $1.38 per share.
    * Revenue rose 24.2% to $24.20 million from a year ago; 
analysts
expected $23.29 million. 
    * Deciphera Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of $1.51​.
    * The mean earnings estimate of analysts had fallen by
about 8.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Deciphera Pharmaceuticals Inc shares had fallen by 16.0%
this
quarter.
    * The company reported a quarterly loss of $88.4 million.
    * Wall Street's median 12-month price target for Deciphera
Pharmaceuticals Inc is $11.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 7
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated February 8 at 10:37 p.m.
 ​All figures in US dollars unless otherwise stated